Ovation Endurance
Natural health product licensed in Canada
- Licence holder
- Level Trifecta Health and Fitness Inc.
- NPN or DIN-HM
- 80101924
- Status
- Active licence
- Licence date
- 17 June 2020
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| L-valine Source : L-valine | 1,500 mg | Not calculated |
| Potassium Source : Potassium | 200 mg | Not calculated |
| Acide 3-aminopropanoïque Source : Beta-alanine | 1,142.5 mg | Not calculated |
| L-Isoleucine Source : L-isoleucine | 1,500 mg | Not calculated |
Non-medicinal ingredients
Saveur de fraise, Arabinogalactane, Stevia leaf, Saveur de framboise, Saveur de vanille, Acide L-malique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Mesures | 1 Tous les jours |
Uses authorised in Canada
Workout supplement. Athletic support. Source of (an) (essential) amino acid(s) involved in muscle protein synthesis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use this product if you have had a heart attack/myocardial infarction. Do not use this product with other potassium-containing supplements or with potassium-containing salt-substitutes.
Source
Official Health Canada record, licence 80101924
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.